No Data
No Data
Express News | JPMorgan Chase & Co. Decreases Short Position in H-Shares of WuXi AppTec to 0.97% on Sept 10 From 1.71% - HKEX
Hong Kong stocks unusual | Wuxi AppTec (02359) rose nearly 5% again, intending to spend 1 billion yuan to repurchase shares. Management said the short-term impact of the US law is controllable.
wuxi apptec (02359) rose by nearly 5%, as of the press time, rose by 4.66%, at 38.15 Hong Kong dollars, with a turnover of 0.156 billion Hong Kong dollars.
wuxi apptec spent 39.235 million yuan on September 12th to buy back 0.9852 million A-shares.
On September 12, 2024, wuxi apptec (02359.HK) announced that it will repurchase 0.9852 million shares of A-shares for a total of 39.235 million yuan, at a repurchase price ranging from 38.54 to 40.2 yuan per share.
Hong Kong stocks closed (09.12) | Hang Seng Index rose 0.77%, technology and pharmaceutical stocks rose, wuxi apptec (02359) led the blue chips.
Today, the three major stock indexes in Hong Kong collectively rose, with all of them rising more than 1% at one point during the trading session. At the close, the Hang Seng Index rose 0.77% or 131.68 points to 17,240.39 points, with a total daily turnover of 91.68 billion Hong Kong dollars.
[Brokerage Focus] CMB International believes that the current stock price of Wuxi AppTec (02359) reflects extremely pessimistic expectations for its US business and is bullish on valuation rebound.
Jinwu Caixin | Zhongyi Guoji released a research report stating that the US House of Representatives passed the "Biosecurity Act" on September 9, local time. At present, even if the bill is passed, it may only affect a small number of government-funded projects, and the US business of Wuxi Apptec (02359/603259CH) is expected to remain relatively stable. Based on the company's rapidly growing order backlog, the bank believes that the company's profitability is expected to recover. The bank's analysis shows that the current stock price may already reflect extremely pessimistic expectations for the US business and is bullish on valuation rebound. The bank pointed out that customer demand is expected to gradually improve. Wuxi Apptec sees positive signs of improvement in customer demand.
Hong Kong stock market fluctuations | CXO concept stocks continue to rise in early trading. The Biosecurity Law is still waiting for the Senate to vote. Citigroup said that the stock price of the Chinese pharmaceutical company has been undervalued.
CXO concept stocks continued to rise in the morning session. As of the time of writing, Wuxi Bio (02269) rose 4.6% to HK$11.82; Wuxi Apptec (02359) rose 4.51% to HK$35.95; Pharmaron (03759) rose 3.84% to HK$9.73; Asymchem Laboratories (06821) rose 3.84% to HK$41.95.
No Data
No Data
Rachael Ong : Selling?
HappyGotLucky OP Rachael Ong : I sold half...the rest just wait and
HappyGotLucky OP HappyGotLucky OP : Thus is a monster waiting to realise it full potential once the pressure has been released...